Roche Holding to Pay $1.03 Billion for Diagnostics-Firm Stake

Roche Holding agreed to pay $1.03 billion for up to a 56.3% stake in Foundation Medicine Inc. in a collaboration that underscores the growing importance of genetic diagnostics in cancer treatment.



from WSJ.com: US Business http://ift.tt/1AP386e

via IFTTT